Work

Discovery of novel 4-amino-6-arylaminopyrimidine-5-carbaldehyde oximes as dual inhibitors of EGFR and ErbB-2 protein tyrosine kinases

Year: 2008

Type: article

Source: Bioorganic & Medicinal Chemistry Letters

DOI: 10.1016/j.bmcl.2008.05.024

Authors: Guozhang Xu, Lily Lee Searle, Terry V. Hughes, Amanda K. Beck, Peter J. Connolly, Marta C. Abad, Michael P. Neeper, Geoffrey T. Struble, Barry A. Springer, Stuart L. Emanuel, Robert H. Gruninger, Niranjan Pandey, Mary Adams, Sandra Moreno-Mazza, Angel R. Fuentes-Pesquera, Steven A. Middleton, Lee M. Greenberger

Institutions: Johnson & Johnson (United States), Janssen Research & Development (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Institute of Microbiology, Chinese Academy of Sciences

OpenAlex ID: W2079731436

FWCI: 4.223

Cites: 22

Cited by: 55

Related to: 10